Joseph H. Griffith IV - 01 Feb 2026 Form 4 Insider Report for 908 Devices Inc. (MASS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Feb 2026, 20:45:22 UTC
Prior SEC filing
06 Oct 2025
Next SEC filing
29 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark S. Levine, Attorney-in-Fact

Key filing fact

Joseph H. Griffith IV filed Form 4 for 908 Devices Inc. (MASS) on 03 Feb 2026.

Key facts

  • This page summarizes Joseph H. Griffith IV's Form 4 filing for 908 Devices Inc. (MASS).
  • 11 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 03 Feb 2026, 20:45.

Change

  • Previous filing in this sequence was filed on 06 Oct 2025.
  • Current net transaction value: -$143,222.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001431531 Primary reporting owner

Griffith Joseph H. IV

Relationship
Chief Financial Officer
Address
C/O 908 DEVICES INC., 44 3RD AVENUE, BURLINGTON
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Signature date
03 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MASS transaction

Common Stock

Options Exercise

Transaction value
Shares
+5,102
Change %
+5.5%
Price
Shares after
98,032
Date
01 Feb 2026
Ownership
Direct
Footnotes
F1
MASS transaction

Common Stock

Options Exercise

Transaction value
Shares
+10,306
Change %
+11%
Price
Shares after
108,338
Date
01 Feb 2026
Ownership
Direct
Footnotes
F1
MASS transaction

Common Stock

Options Exercise

Transaction value
Shares
+11,260
Change %
+10%
Price
Shares after
119,598
Date
01 Feb 2026
Ownership
Direct
Footnotes
F1
MASS transaction

Common Stock

Options Exercise

Transaction value
Shares
+43,473
Change %
+36%
Price
Shares after
163,071
Date
01 Feb 2026
Ownership
Direct
Footnotes
F1
MASS transaction

Common Stock

Sale

Transaction value
$143,222
Shares
-23,175
Change %
-14%
Price
$6.18
Shares after
139,896
Date
02 Feb 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MASS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-5,102
Change %
-100%
Price
$0.000000
Shares after
0
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,102
Exercise price
Footnotes
F1, F4
MASS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-10,306
Change %
-50%
Price
$0.000000
Shares after
10,306
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,306
Exercise price
Footnotes
F1, F5
MASS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-11,260
Change %
-33%
Price
$0.000000
Shares after
22,521
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,260
Exercise price
Footnotes
F1, F6
MASS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-43,473
Change %
-33%
Price
$0.000000
Shares after
86,945
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
43,473
Exercise price
Footnotes
F1, F7
MASS transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+121,164
Change %
Price
$0.000000
Shares after
121,164
Date
02 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
121,164
Exercise price
Footnotes
F1, F8
MASS transaction Derivative

Stock Option (option to buy)

Award

Transaction value
$0
Shares
+52,967
Change %
Price
$0.000000
Shares after
52,967
Date
02 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
52,967
Exercise price
$6.19
Footnotes
F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.105 to $6.35, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F4

These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2022, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

Footnote F5

These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

Footnote F6

These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

Footnote F7

The RSUs shall vest one-third on February 1, 2026, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

Footnote F8

The RSUs shall vest one-third on February 1, 2027, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

Footnote F9

One-third of the shares underlying the option become vested and exercisable on February 1, 2027, and the remaining two-thirds of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 24 months following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .